Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Total Current Liabilities (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Total Current Liabilities over the past 15 years, most recently at $30.2 million for Q2 2025.

  • Quarterly results put Total Current Liabilities at $30.2 million for Q2 2025, down 22.37% from a year ago — trailing twelve months through May 2025 was $30.2 million (down 22.37% YoY), and the annual figure for FY2025 was $30.2 million, down 22.37%.
  • Total Current Liabilities for Q2 2025 was $30.2 million at Lifecore Biomedical, Inc. \De\, down from $31.1 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for LFCR hit a ceiling of $195.6 million in Q4 2022 and a floor of $30.2 million in Q2 2025.
  • Median Total Current Liabilities over the past 5 years was $40.4 million (2023), compared with a mean of $81.1 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 73.37% in 2022 and later crashed 80.19% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Total Current Liabilities stood at $122.4 million in 2021, then soared by 59.83% to $195.6 million in 2022, then tumbled by 79.42% to $40.3 million in 2023, then decreased by 12.33% to $35.3 million in 2024, then fell by 14.49% to $30.2 million in 2025.
  • The last three reported values for Total Current Liabilities were $30.2 million (Q2 2025), $31.1 million (Q1 2025), and $35.3 million (Q4 2024) per Business Quant data.